# Alkermes plc. (ALKS) — capital_raise/public_offering [announced]
Source: SEC API (secapi.ai) · situation sit_942a9c082e34b0519dce · retrieved 2026-08-14T08:08:12.983Z

## Overview
Alkermes plc is a pharmaceutical company that develops and commercializes medicines for central nervous system disorders and other therapeutic areas.

On August 12, 2026, Alkermes plc amended its senior secured credit agreement dated February 12, 2026. The amendment reduced the interest rate spread under the Term Loan A Facility (TLA) by 0.75% and under the Term Loan B Facility (TLB) by 0.50%. The TLA Facility has an outstanding principal amount of $745,312,500 maturing February 12, 2031, and the TLB Facility has an outstanding principal amount of $773,062,500 maturing August 12, 2031. The amendment also refinanced all outstanding Initial Tranche B Term Loans with 2026 Refinancing Tranche B Term Loans.

## Terms
- Counterparty: JPMorgan Chase Bank, N.A., BofA Securities, Inc., and other lenders

## Key dates
- Announced 2026-08-12

## Timeline
- 2026-08-12 · 8-K (0001193125-26-345901): 8-K - Alkermes plc. — *Alkermes plc is a pharmaceutical company that develops and commercializes medicines for central nervous system disorders and other therapeutic areas.* On August 12, 2026, Alkermes plc amended its senior secured credit agreement dated February 12, 2026. The amendment reduced the interest rate spread under the Term Loan A Facility (TLA) by 0.75% and under the Term Loan B Facility (TLB) by 0.50%. The TLA Facility has an outstanding principal amount of $745,312,500 maturing February 12, 2031, and the TLB Facility has an outstanding principal amount of $773,062,500 maturing August 12, 2031. The amendment also refinanced all outstanding Initial Tranche B Term Loans with 2026 Refinancing Tranche B Term Loans.
  https://www.sec.gov/Archives/edgar/data/1520262/0001193125-26-345901.txt

## Citations
- 0001193125-26-345901 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526345901
